Ginkgo Bioworks Buys Synthetic DNA Firm Gen9

02.02.2017 - US biotech firm Ginkgo Bioworks has acquired Gen9, a provider of synthetic DNA, for an undisclosed sum. The acquisition, said Ginkgo, will bring Gen9’s expertise in assembling...